Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$27,000.00
Exploring Neurodevelopmental Impacts of SETD2 Mutations Through Single-Cell Multiomics
EF 2024-25
Résumé
Neurodevelopmental disorders (NDDs) affect 1 in 10 children in Canada and encompass cognitive, behavioral, and motor impairments. Despite their prevalence, the biological mechanisms underlying these disorders remain poorly understood. Mutations in SETD2, a gene crucial for regulating gene expression through chromatin modification, are linked to severe NDDs. Depending on the mutation, these genetic changes can result in contrasting conditions, such as Luscan-Lumish Syndrome (brain overgrowth and mild disability) or Rabin-Pappas Syndrome (brain underdevelopment and profound disability). However, how SETD2 mutations alter brain development at the cellular level is still unclear. This project will use cerebral organoids;lab-grown models of the developing human brain derived from stem cells;to study the impact of SETD2 mutations on neurodevelopment. Cutting-edge single-cell RNA and ATAC sequencing will help analyze gene expression and chromatin accessibility at the single-cell level. By comparing organoids with SETD2 mutations to normal controls, this research will uncover how these mutations affect cellular composition, differentiation, and regulatory pathways. Preliminary observations show striking phenotypic differences, including smaller organoid size, vesicle extrusion, and changes in neural progenitor cells. Using integrated multi-omics approaches, this project aims to identify disrupted regulatory networks and signaling pathways. This work will provide critical insights into how SETD2 mutations drive NDDs, informing future strategies for genetic screening and therapies to improve outcomes for affected individuals.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530112
Name
Seyfourian Parsa
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring Neurodevelopmental Impacts of SETD2 Mutations Through Single-Cell Multiomics
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain Development; Chromatin Modification; Dna Methylation; Epigenetics; Luscan-Lumish & Rabin-Pappas Syndromes; Neurodevelopmental Disorders; Organoids; Setd2; Single-Cell Atac Sequencing; Single-Cell Rna Sequencing
Abstract
Neurodevelopmental disorders (NDDs) affect 1 in 10 children in Canada and encompass cognitive, behavioral, and motor impairments. Despite their prevalence, the biological mechanisms underlying these disorders remain poorly understood. Mutations in SETD2, a gene crucial for regulating gene expression through chromatin modification, are linked to severe NDDs. Depending on the mutation, these genetic changes can result in contrasting conditions, such as Luscan-Lumish Syndrome (brain overgrowth and mild disability) or Rabin-Pappas Syndrome (brain underdevelopment and profound disability). However, how SETD2 mutations alter brain development at the cellular level is still unclear. This project will use cerebral organoids;lab-grown models of the developing human brain derived from stem cells;to study the impact of SETD2 mutations on neurodevelopment. Cutting-edge single-cell RNA and ATAC sequencing will help analyze gene expression and chromatin accessibility at the single-cell level. By comparing organoids with SETD2 mutations to normal controls, this research will uncover how these mutations affect cellular composition, differentiation, and regulatory pathways. Preliminary observations show striking phenotypic differences, including smaller organoid size, vesicle extrusion, and changes in neural progenitor cells. Using integrated multi-omics approaches, this project aims to identify disrupted regulatory networks and signaling pathways. This work will provide critical insights into how SETD2 mutations drive NDDs, informing future strategies for genetic screening and therapies to improve outcomes for affected individuals.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Seyfourian, Parsa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~